Literature DB >> 22486867

Characterization and usefulness of stool antigen tests using a monoclonal antibody to Helicobacter pylori catalase.

Masami Sato1, Tadashi Shimoyama, Ryoki Takahashi, Hirofumi Kajiyama, Yukari Sano, Naomi Sakaedani, Azusa Kato, Haruhisa Hirata, Yoshihiro Fukuda.   

Abstract

BACKGROUND AND AIM: Two types of stool antigen tests have been used in the management of Helicobacter pylori infection. Testmate Pylori Antigen enzyme immunoassay (TPAg EIA) is a direct sandwich enzyme immunoassay (EIA) while Testmate Rapid Pylori Antigen (Rapid TPAg) is performed using immunochromatography. The aim of this study was to study the characterization and usefulness of these tests.
METHODS: Accuracy of both tests was studied using 111 fecal samples obtained from H. pylori-positive or -negative patients. Cross-reactivity was examined with four other Helicobacter spp. and five fecal bacteria in humans. To estimate the sensitivity of both kits, we tested H. pylori clinical strains. We also examined the diagnostic performances of both tests after the storage for 12 months.
RESULTS: The accuracy of both Testmate kits was 100% in fecal samples from 111 patients. No cross-reactivity was observed in both Testmate kits in five fecal bacteria and four other Helicobacter spp. TPAg EIA and Rapid TPAg showed positive results in 1342 of 1344, and 483 of 485 clinical strains, respectively. Diagnostic performances was maintained for 12 months when TPAg EIA was stored at 4°C and Rapid TPAg at 30°C.
CONCLUSIONS: We examined the details of high accuracy of TPAg EIA and Rapid TPAg. The diagnostic performance of both kits was maintained after storage for up to 1 year. The two types of tests would be useful in the management of H. pylori infection.
© 2012 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22486867     DOI: 10.1111/j.1440-1746.2012.07066.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  14 in total

1.  Evaluation of a Novel Stool Antigen Rapid Test Kit for Detection of Helicobacter pylori Infection.

Authors:  Toshihiko Kakiuchi; Masumi Okuda; Kazutoshi Hashiguchi; Ichiro Imamura; Aiko Nakayama; Muneo Matsuo
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

2.  Serum pepsinogen levels indicate the requirement of upper gastrointestinal endoscopy among Group A subjects of ABC classification: a multicenter study.

Authors:  Daisuke Chinda; Tadashi Shimoyama; Tatsuya Mikami; Tetsu Arai; Daisuke Chiba; Yoshio Sasaki; Kazuo Komai; Yoshihiko Sawada; Yoshiharu Saito; Hironobu Chiba; Shinsaku Fukuda
Journal:  J Gastroenterol       Date:  2018-01-20       Impact factor: 7.527

3.  Association of Helicobacter pylori and parasitic infections in childhood: impact on clinical manifestations and implications.

Authors:  Yasmin F Abd El Hameed; Abdallah M Boghdadi; Carolyne M Ghobrial; Marwa A Hassan
Journal:  J Parasit Dis       Date:  2021-02-23

Review 4.  Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Clin Microbiol Rev       Date:  2022-04-11       Impact factor: 50.129

Review 5.  Stool antigen tests for the management of Helicobacter pylori infection.

Authors:  Tadashi Shimoyama
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

Review 6.  Helicobacter pylori infection - recent developments in diagnosis.

Authors:  Ana Isabel Lopes; Filipa F Vale; Mónica Oleastro
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

Review 7.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

8.  Application of Convolutional Neural Networks in the Diagnosis of Helicobacter pylori Infection Based on Endoscopic Images.

Authors:  Satoki Shichijo; Shuhei Nomura; Kazuharu Aoyama; Yoshitaka Nishikawa; Motoi Miura; Takahide Shinagawa; Hirotoshi Takiyama; Tetsuya Tanimoto; Soichiro Ishihara; Keigo Matsuo; Tomohiro Tada
Journal:  EBioMedicine       Date:  2017-10-16       Impact factor: 8.143

9.  Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens.

Authors:  Tadashi Shimoyama; Daisuke Chinda; Yoshihiko Sawada; Kazuo Komai; Hironobu Chiba; Yoshiharu Saito; Yoshio Sasaki; Masashi Matsuzaka; Shinsaku Fukuda
Journal:  Intern Med       Date:  2017-07-01       Impact factor: 1.271

10.  A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication.

Authors:  Hiroki Osumi; Junko Fujisaki; Takanori Suganuma; Yusuke Horiuchi; Masami Omae; Toshiyuki Yoshio; Akiyoshi Ishiyama; Tomohiro Tsuchida; Kazumasa Miki
Journal:  PLoS One       Date:  2017-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.